spacer
home > pmps > autumn 2008 > coding and vision: keys to traceability
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Coding and Vision: Keys to Traceability

In order to complement technological advances, direct part marking and machine vision have continuously evolved to satisfy consumer demands and industry regulations. This article highlights the capabilities and importance of coding, marking and vision and how, as a combined force, they ensure complete product traceability within both traditional manufacturing and, more recently, in the logistics arena.

THE RISE OF TRACEABILITY

As consumer demands continue to spiral upwards, and with a blanket of stringent legislation and regulations covering all areas of manufacturing, the need for a product to be traced from ‘cradle to grave’ has been of paramount importance for some time. This not only appeases the regulators, but delights the end users who would receive their products, supplied as per the agreed requirements.

Before long, the buzzwords of ‘coding’ and ‘traceability’were on everyone’s lips, and the increase in machine vision usage became...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Leigh Jordan attained a BEng Hons in Integrated Engineering from the University of Wales, and has been working with machine vision since 1994. He joined Cognex in 1999 as an Applications Engineer and ID Specialist. In 2004, Leigh moved to ID Product Marketing for the Cognex ID Business Unit, where he supports key ID accounts with a direct responsibility for ID product strategy for the international region.
spacer
Leigh Jordan
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

3P Biopharmaceuticals welcomes Keensight Capital as majority shareholder


More info >>

White Papers

Conveying Medical Guidance in Clinical Trials – A Survey

Europital Medical Consultancy

With the incremental demand for proactive safety surveillance throughout the conduct of clinical trials, the role of Medical Management is at the fore in ensuring the safety and wellbeing of the participants. The complex responsibilities of a Medical Monitor (MM) starts from the design and development phase, through to study close out. Understanding the principle behind the protocol and the prospective medical solution the study would deliver forms the bloodline for the MM role. Often, the MM is the face of contact for both the site personnel and the study team members with regard to medical, safety and scientific issues within the project. When it comes to medical guidance, the communication channel used to deliver solutions contributes to a large extent in effectively managing decisive situations. Our previous study on acquiring medical guidance from an operations team perspective revealed that e-mails were the most used communication method (see the article, 'Talking Points', in ICT November 2014). In our efforts to further strengthen the mode of medical guidance delivery, we designed a survey to study the existing trend and constraints in this communication chain management, as outlined here.
More info >>

 
Industry Events

Clinical Trial Supply Europe

11-12 March 2020, Madrid, Spain

The 21st annual edition promises to grow on the success of 2019’s excellent conference which saw delegates from Europe’s largest pharmaceutical companies and biotech innovators come together to discuss, debate and unpack the latest trends in clinical supply chain innovation. 2020 will offer delegates the opportunity to address the growing need for agility within the supply chain in response to increasingly complex trial demands. With a stream dedicated to supply operations and another to innovative uses of technology in the supply chain, delegates will get the chance to gain practical take-aways that they can apply to their own studies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement